Login / Signup

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.

Brioni R MooreWendy A DavisPhilip M ClarkeLeanne J RobinsonMoses LamanTimothy M E Davis
Published in: Malaria journal (2017)
Whilst AN has superior overall efficacy for the treatment of uncomplicated malaria in PNG children, AL was the less costly regimen. An indicative extrapolation estimated the cost per life year saved by using AN instead of AL to treat uncomplicated malaria to be $12,165 for girls and $12,469 for boys (discounted), which means AN may not be cost-effective and affordable for PNG at current cost. However, AN may become acceptable should it become WHO prequalified and/or should donated/subsidized drug supply become available.
Keyphrases
  • plasmodium falciparum
  • young adults
  • urinary tract infection
  • combination therapy
  • adverse drug
  • drug induced